Trial · NCT03386149
Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine
NCT03386149, Phase 3, Completed, Kyunghee University Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine. Trials, record NCT03386149. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03386149
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine
- NCT number
- NCT03386149
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 74 participants, actual
- Lead sponsor
- Kyunghee University Medical Center
- Conditions
- Lumbar Disc Herniation
- Interventions
- Bosinji, Loxonine tab., Acupuncture
- First posted
- 2017-12-29
- Last updated
- 2020-02-05
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline 100mm Pain Visual Analogue Scale (VAS) for low back pain at Week 6 | Week 0 (Baseline), Week 3, Week 6 (Primary end point, Treatment end), Week 10 (F/U) | Measurement instrument for subjective pain |
| Secondary | 100mm Pain Visual Analogue Scale (VAS) for radiating pain | Week 0 (Baseline), Week 3, Week 6 (Primary end point, Treatment end), Week 10 (F/U) | Measurement instrument for subjective pain |
| Secondary | Oswestry Disability Index (ODI) | Week 0 (Baseline), Week 3, Week 6 (Primary end point, Treatment end), Week 10 (F/U) | Validated questionnaire for disability of low back pain |
| Secondary | EuroQol-5 dimensions-5 level (EQ-5D-5L) | Week 0 (Baseline), Week 3, Week 6 (Primary end point, Treatment end), Week 10 (F/U) | Standardized instrument for generic health status |
| Secondary | Roland-Morris Disability Questionnaire (RMDQ) | Week 0 (Baseline), Week 3, Week 6 (Primary end point, Treatment end), Week 10 (F/U) | Health status measure for low back pain |
| Secondary | Global Perceived Effect (GPE) | Week 3, Week 6 (Primary end point, Treatment end), Week 10 (F/U) | Assessment of change in the patient's chief complaint |
| Secondary | Deficiency Syndrome of Kidney Index (DSKI) | Week 0 (Baseline), Week 6 (Primary end point, Treatment end) | Questionnaire for assessing symptoms related to deficiency syndrome of kidney |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03386149
GET https://conductscience.org/api/trials/v1/NCT03386149/registered